- 1Emergency Department, Zigong Fourth People’s Hospital, Zigong, China
- 2Emergency Department, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
- 3Emergency Department, Affiliated Hospital of Southwest Medical University, Luzhou, China
Introduction: Hepatic tuberculosis is a rare disease entity even in endemic areas of Mycobacterium tuberculosis. It is usually accompanied by pulmonary tuberculosis or enteric tuberculosis. Due to the non-specific clinical symptoms and imaging features may lead to misdiagnosis and even unnecessary surgery.
Case presentation: A 44-year-old woman presented with complaints of abdominal pain for the past 2 months. The patient was diagnosed with a solitary hepatic tuberculosis abscess that was identified by abdominal CT and liver biopsy. The patient was started on anti-tuberculous therapy (isoniazid, rifampin, ethambutol, pyrazinamide). One month after diagnosis, an abdominal ultrasound showed the abscess had enlarged to approximately 4.4 cm × 3.4 cm, with heterogeneous echogenicity and internal septations. The patient subsequently went to a specialist hospital for further treatment. Telephone follow-up revealed that the patient continued anti-tuberculosis treatment, with symptoms gradually improving and essentially resolving after 6 months.
Conclusion: Hepatic tuberculosis is relatively rare in clinical practice and can easily be misdiagnosed as hepatocellular and cholangiocellular carcinoma, leading to unnecessary surgery. Postoperative pathological examination confirms the diagnosis of hepatic tuberculosis. A solitary tuberculous liver abscess creates a clinical barrier for treating physicians. We summarized cases that have been misdiagnosed as tumors over the past 20 years. When encountering suspicious patients clinically, it is important to inquire in-depth about the history of tuberculosis and to perform an ultrasound-guided liver lesion biopsy for pathological examination as early as possible to achieve early diagnosis and treatment.
1 Introduction
Tuberculosis (TB) is a global health issue with particularly high prevalence in developing countries. The global burden of tuberculosis was estimated to be 10.6 million cases in 2022 (1). Abdominal tuberculosis is one of the most common extrapulmonary diseases (2). The incidence of liver involvement is less than 1% and it is usually associated with pulmonary or gastrointestinal infection foci (3). Primary hepatobiliary tuberculosis is considered very rare in abdominal tuberculosis. It is sporadically reported in the literature. Hepatic tuberculosis lacks typical clinical manifestations and may be difficult to distinguish from other malignant tumors, such as hepatocellular carcinoma, intrahepatic cholangiocarcinoma, cholangiocarcinoma, and liver abscesses. Hepatic tuberculosis may lead to misdiagnosis and even unnecessary surgery. Here, we report a case of a solitary tuberculous liver abscess and review the relevant literature.
2 Case summary
A 44-year-old woman presented with complaints of abdominal pain for the past 2 months. The patient’s abdominal pain was intermittent, lasting from several minutes to several hours. It was accompanied by a decreased appetite, fever, and night sweats. However, there were no symptoms of nausea, vomiting, changes in bowel movements, chills, or cough with sputum production. The patient was born and currently resides in Luzhou City, Sichuan Province, China. She is a company clerk and denies any history of contact with animals or tuberculosis. She also reports no past medical history of liver disease, tuberculosis, or acquired immune deficiency syndrome (AIDS). In the past year, she had not experienced any weight loss or traveled outside of Luzhou. She was dyspneic (RR = 20 breaths/min), had a temperature of 36.5 °C, a heart rate of 70 beats per minute, blood pressure of 118/78 (normal range, 60–90/90–140) mmHg, and a 33% oxygen saturation on room air at the time of admission. Abdominal examination revealed periumbilical and right lower abdominal wall tenderness and rebound pain. The rest of the system examination was unremarkable. The chest computed tomography (CT) was normal. The contrast-enhanced abdominal CT scan shows a small amount of ascites in the lesser omentum sac and the abdominal and pelvic cavities, with the pelvic cavity being the main site. The greater omentum, mesentery, and peritoneum are extensively thickened, with some areas showing nodular thickening. These are all manifestations of tuberculous peritonitis. The contrast-enhanced CT also reveals a round, low-density, non-enhancing shadow in the right anterior lobe of the liver, with a diameter of approximately 0.8 cm. There is a patchy enhancement in the left medial lobe of the liver during the arterial phase, and the enhancement is consistent with the surrounding liver parenchyma during the venous phase. The hepatic CT showed an irregular mass of approximately 4.1 cm × 3.1 cm in the right anterior space of the liver, part of which invaded the right anterior lobe of the liver (Figure 1a). The findings are consistent with an infection complicated by abscess formation involving the anterior segment of the right hepatic lobe. The right lobe of the liver’s ultrasound revealed a cystic dark region measuring 3.7 cm × 2.1 cm (Figure 1b). To confirm the diagnosis, we performed a liver biopsy (4). Ultrasound-guided biopsy of the lesion was done, which showed chronic granulomatous inflammation suggestive of tuberculosis (Figure 1c). The tuberculin test was positive. TB-DNA real-time PCR performed on the aspirated pus was positive, confirming the presence of M. tuberculosis complex DNA. Her total leucocyte count was 7.01 (normal range, 3.5–9.5) × 109/L, neutrophil count was 5.56 (normal range, 1.8–6.3) × 109/L, platelet count was 229 (normal range, 100–350) × 109/L, C-reactive protein (CRP) level was 10.65 mg/L, and erythrocyte sedimentation rate (ESR) was 33 mm3. The renal function and electrolyte tests showed urea, 5 (normal range, 3.1–8.0) mmol/L; uric acid, 231 (normal range, 208–428) μmol/L; glomerular filtration rate, 100 (normal range, ≥90) mL/min; creatinine, 72 (normal range, 57–97) μmol/L; potassium, 4.15 (normal range, 3.5–5.3) mmol/L; sodium, 140 (normal range, 137–147) mmol/L; and chloride, 105.2 (normal range, 99–110) mmol/L. The liver function tests showed alanine aminotransferase, 80 (normal range, 9–50) U/L; aspartate aminotransferase, 78 (normal range, 15–40) U/L; total bilirubin, 17 (normal range, 0–26) U/L; direct bilirubin, 8.6 (normal range, 0–8) U/L; indirect bilirubin, 8.4 (normal range, 0–20) U/L; and albumin, 35 (normal range, 40–55) g/L. Blood culture was negative. The carcinoembryonic antigen, CA-19.9, CA-125, and a-fetoprotein serum tumor markers were all within normal limits. The HIV test was negative. She was diagnosed with hepatic tuberculosis and tuberculous peritonitis. Anti-tuberculous medication (isoniazid, rifampin, ethambutol, pyrazinamide) was initiated for the patient. The abscess’s size had increased on the abdominal ultrasonography performed 1 month after the diagnosis (Figure 1d). Abdominal ultrasound revealed a 4.4 cm × 3.4 cm area of heterogeneous echogenicity in the anterior segment of the right hepatic lobe, with ill-defined borders, hypoechoic areas, and internal septations. After discharge, the patient continued to be managed and followed up as an outpatient, but she took herself to a specialized infectious-disease hospital immediately after this repeat ultrasound. During the subsequent period, telephone follow-up indicated that the patient continued anti-tuberculosis therapy (the specific regimen was not documented), with symptoms gradually improving and essentially resolving after 6 months.
Figure 1. Rare case of tuberculosis liver abscess. (a) The abdominal hepatic CT scan revealed a single, well-defined focal lesion measuring 0.8 cm in the low-density area of the right liver lobe and an irregular mass measuring approximately 4.1 cm × 3.1 cm in the right anterior space of the liver (red arrow). (b) Ultrasound of the abdomen showed a cystic dark area of 3.7 cm × 2.1 cm in the right posterior lobe of the liver (red arrow). (c) Hematoxylin–eosin staining shows chronic granulomatous inflammation suggestive of tuberculosis (HE ×200). (d) The abdominal ultrasound reveals a noteworthy enlargement of the abscess, measuring 4.4 cm × 3.4 cm (red arrow).
3 Discussion
Worldwide, tuberculosis still exists. Because of the epidemic of acquired immunodeficiency syndrome, intravenous drug usage, and antibiotic resistance, the incidence of hepatic tuberculosis has grown (5, 6). Of all extra-pulmonary locales, hepatic TB accounts for 3%, and intra-abdominal regions for 9%. Levine (7) divided TB of the liver into five categories: (1) pulmonary TB involving the liver, (2) miliary TB, (3) primary liver TB, (4) focal abscess or tuberculoma, and (5) tuberculous cholangitis. Herein, we describe a case of a 44-year-old woman who presented with abdominal pain, with no prior history of immunodeficiency. A CT scan revealed an abscess in the right lobe of the liver and tuberculous peritonitis. An ultrasound-guided biopsy of the lesion showed chronic granulomatous inflammation, suggesting tuberculosis. The tuberculosis DNA test was positive. Our diagnosis was primarily based on imaging and biopsy results.
Hepatic TB refers to the infection of the liver with Mycobacterium tuberculosis, which is clinically rare. Depending on whether there is extrahepatic tuberculosis accompanying the infection of the liver by Mycobacterium tuberculosis, it can be divided into primary and secondary (8). Secondary hepatic tuberculosis is usually combined with pulmonary tuberculosis or tuberculous enterocolitis (9). In this case, when hepatic tuberculosis was found, no other definite tuberculosis lesions were found, and it is considered that this case is primary hepatic tuberculosis.
Mycobacterium tuberculosis spreads to the liver through hematogenous dissemination. Miliary hepatic tuberculosis is Mycobacterium tuberculosis entering the liver through the hepatic artery, and focal hepatic tuberculosis enters the liver through the portal vein; a few can directly invade the liver through the lymphatic system or adjacent lesions (10). Solitary tuberculous liver abscesses are extremely rare and have rarely been described in the literature. Mycobacterium tuberculosis does not always form hepatic tuberculosis after invading the liver. Because the liver has a rich blood supply, contains a large number of mononuclear phagocytic cells, and has a strong ability to regenerate and repair, and because bile and the low-oxygen blood of the liver are not conducive to the growth of Mycobacterium tuberculosis, it is not easy to form lesions. In this case, the patient did not have an endoscopy scheduled because no symptoms or indicators of enterocolitis were noted during the illness.
Due to the non-specific clinical symptoms and imaging manifestations, hepatic TB is easy to be misdiagnosed (11). Most patients may be asymptomatic, but Esguerra-Paculan and Soldera (12) found that patients may present with symptoms such as hepatomegaly, fever, weakness, night sweats, or abdominal pain (13). Radiological findings can mimic common liver disorders, including tumors, abscesses, or hemangiomata (14). Due to the non-specific clinical features and laboratory test results of hepatic tuberculosis and malignant tumors, it is challenging to distinguish hepatic tuberculosis from malignant tumors, particularly in differentiating it from intrahepatic cholangiocarcinoma. A review of the literature reveals cases where liver abscesses were misdiagnosed as liver tumors and underwent surgical treatment (Table 1). Kale et al. (15) retrospectively analyzed the clinical data of 43 patients at the cancer center and found that one of the imaging characteristics of hepatic tuberculosis is punctate or mass-like calcification. Tumor marker levels can also serve as one of the bases for differential diagnosis, but a definitive diagnosis must rely on pathological examination. Ultrasound/CT-guided percutaneous biopsy has become an important means of reducing unnecessary surgery. This case report describes a case of a tuberculous liver abscess initially presenting with abdominal pain, which was confirmed by liver biopsy. The patient’s tumor marker levels were normal, and the liver CT did not reveal any punctate or mass-like calcifications.
Once diagnosed with hepatic tuberculosis, anti-tuberculosis treatment should be started immediately, and anti-tuberculosis treatment should also be started as early as possible if there is strong suspicion of hepatic tuberculosis (5). Early combination therapy with multiple drugs can bring relatively good results; however, delayed diagnosis may lead to liver failure or even death. Treatment for hepatic tuberculosis can involve drug-based anti-tuberculosis and surgical drainage. Drug therapy often uses a regimen primarily consisting of isoniazid, rifampicin, pyrazinamide, and ethambutol (13, 16). A review of the literature suggests that when the effects of anti-tuberculosis treatment are poor, surgical drainage is recommended (13). In this case, the increase in abscess size could be attributed to either treatment failure or an effective therapeutic response accompanied by liquefaction and fibrous septation within the lesion. At the outpatient follow-up, the patient reported less abdominal pain and liver-function tests remained within normal limits, while ultrasound showed a modest increase in abscess size (from 3.7 cm × 2.1 cm to 4.4 cm × 3.4 cm) with indistinct margins, a few hypoechoic areas and internal septations, findings that—taken together with her improved symptoms and biochemistry—lead us to infer that therapy is effective. Unfortunately, she did not remain under our care or follow-up, precluding verification of this inference and complete data acquisition.
4 Strengths and limitations
Isolated hepatic tuberculosis in an immunocompetent patient is extremely rare. We conducted a systematic review of cases misdiagnosed and subjected to surgical treatment over the past two decades, revealing a worldwide pattern of unnecessary surgery resulting from such misdiagnosis and underscoring the clinical importance of early biopsy. Nevertheless, the present case report has limitations: comprehensive long-term follow-up data are lacking, and details of subsequent treatment, imaging follow-up, and outcome were obtained only by telephone interview. Despite these constraints, our report highlights the risk of misdiagnosis—a message that retains significant clinical value.
5 Conclusion
Hepatic tuberculosis is relatively rare in clinical practice, and some patients lack or omit a history of tuberculosis during consultation. Coupled with atypical clinical manifestations, relying solely on imaging examination results may lead to misdiagnosis and even unnecessary surgery. Tuberculous liver abscesses pose a challenge to the clinical acuity of treating physicians. When encountering suspicious patients in the clinic, a thorough inquiry about the history of tuberculosis should be conducted, and an ultrasound-guided liver lesion biopsy for pathological examination should be performed as early as possible to achieve an early diagnosis and timely treatment.
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The requirement of ethical approval was waived by the Ethics Committee of the Affiliated Hospital of Southwest Medical University for the studies on humans because this study was carried out and reported anonymously, using data from the clinical workouts. Written and informed consent was obtained from the patient for any personal or medical information to be published in this case report. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and institutional requirements. The human samples used in this study were acquired from a by-product of routine care or industry. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
LL: Writing – original draft, Resources, Validation, Data curation, Conceptualization, Visualization. JZ: Data curation, Visualization, Writing – original draft. QS: Writing – review & editing, Supervision, Conceptualization. LC: Writing – review & editing, Visualization, Project administration, Conceptualization, Supervision.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. This research was supported by the Zigong Science and Technology Program (2023YLWS05), and Research Project of Zigong City Science & Technology and Intellectual Property Right Bureau (2021ZC22).
Acknowledgments
We are grateful that the patient gave us clinical information.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The authors declare that no Gen AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. World Health Organization. Global tuberculosis report 2023. Geneva: World Health Organization (2023).
2. Singh, S, Jain, P, Aggarwal, G, Dhiman, P, Singh, S, and Sen, R. Primary hepatic tuberculosis: a rare but fatal clinical entity if undiagnosed. Asian Pac J Trop Med. (2012) 5:498–9. doi: 10.1016/S1995-7645(12)60085-6
4. Landen, S, Ballet, T, Bollars, P, Badic, B, Herman, D, and Delugeau, V. Liver tuberculosis mistaken for malignancy. The role of needle biopsy. Acta Gastroenterol Belg. (2010) 73:278–9.
5. Khanijo, S, and Tandon, P. A case of hepatic tuberculosis: a tuberculoma. Indian J Tuberc. (2018) 65:91–3. doi: 10.1016/j.ijtb.2017.08.009
6. Parsak, CK, Hanta, I, Aslan, A, and Alabaz, O. Isolated hepatic tuberculosis presenting as cystic-like and tumour-like mass lesions. Case Rep Gastroenterol. (2008) 2:18–21. doi: 10.1159/000113221
7. Levine, C. Primary macronodular hepatic tuberculosis: US and CT appearances. Gastrointest Radiol. (1990) 15:307–9. doi: 10.1007/BF01888805
8. Akçay, MN, Polat, KY, Oren, D, and Oztürk, G. Primary tuberculous liver abscess. A case report and review of literature. Int J Clin Pract. (2004) 58:625–7. doi: 10.1111/j.1368-5031.2004.00105.x
9. Abdelmahmuod, EA, Elayana, M, Subahi, E, Aker, L, Alamin, MA, and Alfitori, G. Tuberculous liver abscess as a unique cause of liver abscess: a case report and literature review. Heliyon. (2023) 9:e20755. doi: 10.1016/j.heliyon.2023.e20755
10. Venkatesh, SK, Tan, LKA, Siew, EPY, and Putti, TC. Macronodular hepatic tuberculosis associated with portal vein thrombosis and portal hypertension. Australas Radiol. (2005) 49:322–4. doi: 10.1111/j.1440-1673.2005.01439.x
11. Sharma, R, Dey, AK, Mittal, K, Udmale, P, Singh, U, Mitkar, S, et al. Hepatic tuberculosis mimicking biliary cystadenoma: a radiological dilemma. Case Rep Surg. (2015) 2015:390184. doi: 10.1155/2015/390184
12. Esguerra-Paculan, MJA, and Soldera, J. Hepatobiliary tuberculosis in the developing world. World J Gastrointest Surg. (2023) 15:2305–19. doi: 10.4240/wjgs.v15.i10.2305
13. Wu, Z, Wang, W-L, Zhu, Y, Cheng, J-W, Dong, J, Li, M-X, et al. Diagnosis and treatment of hepatic tuberculosis: report of five cases and review of literature. Int J Clin Exp Med. (2013) 6:845–50. doi: 10.1155/2013/384894
14. Malik, M, Kurban, L, Murray, GI, and Alkari, B. Isolated tuberculosis of the liver: a diagnostic challenge. BMJ Case Rep. (2011) 2011:bcr1220103654. doi: 10.1136/bcr.12.2010.3654
15. Kale, A, Patil, PS, Chhanchure, U, Deodhar, K, Kulkarni, S, Mehta, S, et al. Hepatic tuberculosis masquerading as malignancy. Hepatol Int. (2022) 16:463–72. doi: 10.1007/s12072-021-10257-9
16. World Health Organization. WHO consolidated guidelines on tuberculosis: Module 4: Treatment—drug-susceptible tuberculosis treatment. Geneva: World Health Organization (2022).
17. Landen, S, Ballet, T, Kessler, R, Badic, B, Costache, M, Dobos, S, et al. Tuberculosis diagnosed after major hepatectomy for suspected malignancy. Acta Chir Belg. (2010) 110:221–4. doi: 10.1080/00015458.2010.11680603
18. Park, J-I. Primary hepatic tuberculosis mimicking intrahepatic cholangiocarcinoma: report of two cases. Ann Surg Treat Res. (2015) 89:98–101. doi: 10.4174/astr.2015.89.2.98
19. Liu, H, Zhu, J, Dong, H, Wang, Y, Ma, J, Kou, J, et al. Isolated hepatic tuberculosis in the caudate lobe mimicking intrahepatic carcinoma. Clin Res Hepatol Gastroenterol. (2017) 41:e65–7. doi: 10.1016/j.clinre.2017.01.001
20. Harbi, H, Chaabouni, A, Kallel, R, Toumi, N, Fendri, S, Krichene, J, et al. Nodular hepatic tuberculosis masquerading as a seminoma liver metastasis. Arch Iran Med. (2018) 21:180–2.
21. Maguire, C, Sivabalan, P, Jhamb, S, and Palamuthusingam, P. Hepatic tuberculosis masquerading as cholangiocarcinoma: an unusual differential for a liver mass. J Surg Case Rep. (2020) 2020:rjaa247. doi: 10.1093/jscr/rjaa247
22. Keri, VC, Jorwal, P, Kodan, P, and Biswas, A. Tuberculosis masquerading as metastasis in liver: a rare and an unusual presentation. BMJ Case Rep. (2020) 13:e233303. doi: 10.1136/bcr-2019-233303
23. Yang, C, Liu, X, Ling, W, Song, B, and Liu, F. Primary isolated hepatic tuberculosis mimicking small hepatocellular carcinoma: a case report. Medicine. (2020) 99:e22580. doi: 10.1097/MD.0000000000022580
Keywords: Mycobacterium tuberculosis, hepatic tuberculosis, misdiagnosis, carcinoma, early biopsy
Citation: Li L, Zhang J, Song Q and Cheng L (2025) Diagnosis of isolated hepatic tuberculosis in an immunocompetent individual: a case report and review of misdiagnosed cases. Front. Med. 12:1687127. doi: 10.3389/fmed.2025.1687127
Edited by:
Yolanda López-Vidal, National Autonomous University of Mexico, MexicoReviewed by:
Qingming Wu, Wuhan University of Science and Technology, ChinaElabbass Abdelmahmuod, Hamad Medical Corporation, Qatar
Copyright © 2025 Li, Zhang, Song and Cheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Qitai Song, ZXJfc3R0QDE2My5jb20=; Lingxia Cheng, Y2x4MjAyMTEwMDhAMTI2LmNvbQ==
†These authors have contributed equally to this work and share last authorship
Jianjun Zhang1